Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Rutgers who wrote (12671)	1/25/2014 1:05:46 PM
From: Mimbari	1 Recommendation Recommended By Mammon Respond to of 13111

The ultimate customer for the pr was big pharma and the FDA. That pr kicked the china deals up a notch I would assume. The parabolic rise in the sp recently was not due to retail shareholders. It was the bear raid people spiraling up the sp and at the peak letting in the retail lambs to be slaughtered. The company did not see the raid coming and once executed had little they could do about it. Now back to what is important...none of this mess affects the end game process. Big pharma got to see the mind of the FDA.

To: Rutgers who wrote (12671)	1/25/2014 3:38:24 PM
From: jm2i123	Respond to of 13111

Agree with you Rutgers on your last points. From what i hear the PR was changed to sthg much softer. The mood had changed with the stock crashing, advisers and lawyers involved, and AF having a 24/7 go at the company. Anything looking potentially dodgy or too good to be true would be a waste of lawyers time with many angry share holders blaming the company for the SP fall and some suing for having said this and that. I think Culpepper had planned a listing, papers were signed etc..and the mood was massively upbeat. Came the nuke and with the FDA on side, they preferred to release sthg softer and reduce the exposure. But i, personally, read the news as good news: the FDA would never agree to a 28 patient OLD data if it wasn't first convinced the drug offers some clear facts. I think the odds are good and AA is still on the table.